Insider · CIK 0001368078

Babich Michael L

Reports to the SEC for 2 companies · CHANDLER, AZ

sec.gov

Transactions

Companies

Filings

CIK

0001368078

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2015-09-22	Insys Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−16.1K sh	—	—	70,000
2015-09-22	Insys Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+16.1K sh	$1.62	+$26K	421,572
2015-05-05	Insys Therapeutics, Inc.Stock Option (right to buy)A Award	Director, President and CEO	AAward	+60K sh	—	—	60,000
2015-03-20	Insys Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+5,000 sh	$3.25	+$16.3K	207,752
2015-03-20	Insys Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−5,000 sh	—	—	38,034
2015-03-17	Insys Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+27.4K sh	$7.26	+$199K	230,152
2015-03-17	Insys Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−1,600 sh	$58.95	−$94.3K	202,752
2015-03-17	Insys Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−13.3K sh	$58.12	−$773K	204,352
2015-03-17	Insys Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−12.5K sh	$57.21	−$715K	217,652
2015-03-16	Insys Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−1,845 sh	—	—	373,155
2015-03-16	Insys Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−27.4K sh	—	—	345,755
2015-03-16	Insys Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+45.8K sh	$2.36	+$108K	248,507
2015-03-16	Insys Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+30K sh	$3.25	+$97.5K	202,752
2015-03-16	Insys Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+1,845 sh	$7.26	+$13.4K	250,352
2015-03-16	Insys Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−8,224 sh	$57.91	−$476K	242,128
2015-03-16	Insys Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−23.5K sh	$59.07	−$1.39M	218,628
2015-03-16	Insys Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−13.5K sh	$59.71	−$809K	205,082
2015-03-16	Insys Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−2,330 sh	$60.62	−$141K	202,752
2015-03-16	Insys Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−30K sh	—	—	43,034
2015-03-16	Insys Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−45.8K sh	—	—	117,995
2014-12-19	Insys Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−2,500 sh	—	—	73,034
2014-12-19	Insys Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+2,500 sh	$3.25	+$8,125	172,295
2014-11-04	Insys Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+7,500 sh	$2.36	+$17.7K	177,295
2014-11-04	Insys Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−7,500 sh	—	—	163,750
2014-11-04	Insys Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−7,500 sh	$37.27	−$280K	169,795
2014-11-03	Insys Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−17.9K sh	$37.58	−$674K	224,373
2014-11-03	Insys Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−13.7K sh	$39.66	−$542K	180,515
2014-11-03	Insys Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−10.7K sh	$40.41	−$433K	169,795
2014-11-03	Insys Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−72.5K sh	—	—	171,250
2014-11-03	Insys Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+72.5K sh	$2.36	+$171K	242,295
2014-11-03	Insys Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−30.2K sh	$38.57	−$1.16M	194,176
2014-10-21	Insys Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−20K sh	—	—	243,750
2014-10-21	Insys Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+20K sh	$2.36	+$47.2K	189,795
2014-10-21	Insys Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−20K sh	—	—	243,750
2014-10-21	Insys Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+20K sh	$3.54	+$70.8K	189,795
2014-10-21	Insys Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−20K sh	$40.17	−$803K	169,795
2014-10-16	Insys Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−5,000 sh	—	—	75,534
2014-10-16	Insys Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+5,000 sh	$3.25	+$16.3K	165,562
2014-10-10	Insys Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+10K sh	$3.25	+$32.5K	160,562
2014-10-09	Insys Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−10K sh	—	—	80,534
2014-08-07	Insys Therapeutics, Inc.Stock Option (right to buy)A Award	Director, President and CEO	AAward	+90K sh	—	—	90,000
2014-03-18	Insys Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+33.1K sh	$4.88	+$162K	95,375
2014-03-18	Insys Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+56.9K sh	$1.83	+$104K	62,251
2014-03-18	Insys Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−56.9K sh	—	—	0
2014-03-18	Insys Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−33.1K sh	—	—	65,356
2014-03-05	Insys Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+211K sh	$1.83	+$386K	293,807
2014-03-05	Insys Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−1,043 sh	$84.72	−$88.4K	105,553
2014-03-05	Insys Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−1,267 sh	$83.92	−$106K	104,286
2014-03-05	Insys Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−1,211 sh	$82.55	−$100K	103,075
2014-03-05	Insys Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−9,085 sh	$81.91	−$744K	93,990

Recent filings

Accepted (ET)
Sep 224
Insys Therapeutics, Inc.0001209191-15-071908
SEC(opens sec.gov)
May 74
Insys Therapeutics, Inc.0001209191-15-039907
SEC(opens sec.gov)
Mar 204
Insys Therapeutics, Inc.0001209191-15-028226
SEC(opens sec.gov)
Mar 184
Insys Therapeutics, Inc.0001209191-15-027512
SEC(opens sec.gov)

Companies

Address

444 SOUTH ELLIS STREET

CHANDLER, AZ, 85224